Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Office of AIDS Research Advisory Council.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Office of AIDS Research Advisory Council.
Date: November 14, 2013.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: The theme of the Office of AIDS Research Advisory
Council (OARAC) meeting will be NIH AIDS Priority-Setting in an Era
of Budget Constraint. The OARAC will devote the full one-day meeting
to reviewing key areas of the portfolio with presentations and
discussions led by leaders in each scientific area including AIDS
vaccines, microbicides, therapeutics research, behavioral research,
disease progression/comorbidities, and research toward a cure. An
update will be provided on the latest changes made to the federal
treatment and prevention guidelines by the OARAC Working Groups
responsible for the guidelines.
Place: National Institutes of Health, 5635 Fishers Lane
Conference Center, Terrace Level, Suite T-500, Rockville, MD 20852.
Contact Person: Robert Eisinger, Ph.D., Executive Secretary,
Director of Scientific And Program Operations, Office of Aids
Research, Office of The DirectoR, NIH, 5635 Fishers Lane, MSC 9310,
Suite 400, Rockville, MD 20852, (301) 496-0357; email@example.com.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: www.oar.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.